Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Aquestive Therapeutics (AQST) stocks in Canada
Learn how to easily invest in Aquestive Therapeutics stocks.
Aquestive Therapeutics is a drug manufacturers-specialty & generic business based in the US. Aquestive Therapeutics stocks (AQST.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.52 – a decrease of 12.88% over the previous week. Aquestive Therapeutics employs 187 staff and has a trailing 12-month revenue of around $46.9 million.
How to buy shares in Aquestive Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AQST – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Aquestive Therapeutics?
- Has coronavirus impacted Aquestive Therapeutics shares?
- Aquestive Therapeutics shares summary
- Compare share dealing platforms
- Is Aquestive Therapeutics stock a buy or sell?
- Aquestive Therapeutics performance over time
- Aquestive Therapeutics's financials
- How volatile are Aquestive Therapeutics shares?
- Does Aquestive Therapeutics pay a dividend?
- Other common questions
Aquestive Therapeutics stock price (NASDAQ:AQST)Use our graph to track the performance of AQST stocks over time.
Aquestive Therapeutics shares at a glance
|Latest market close||$2.57|
|52-week range||$2.60 - $7.00|
|50-day moving average||$4.87|
|200-day moving average||$4.26|
|Wall St. target price||$15.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.70|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Aquestive Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Aquestive Therapeutics price performance over time
|1 week (2022-01-19)||-25.51%|
|1 month (2021-12-27)||-35.10%|
|3 months (2021-10-24)||N/A|
|6 months (2021-07-28)||-26.99%|
|1 year (2021-01-28)||-50.00%|
|2 years (2020-01-28)||-36.70%|
|3 years (2019-01-28)||7.98|
|5 years (2017-01-24)||N/A|
Aquestive Therapeutics financials
|Revenue TTM||$46.9 million|
|Gross profit TTM||$32.9 million|
|Return on assets TTM||-41.76%|
|Return on equity TTM||0%|
|Market capitalisation||$118.5 million|
TTM: trailing 12 months
Aquestive Therapeutics share dividends
We're not expecting Aquestive Therapeutics to pay a dividend over the next 12 months.
Aquestive Therapeutics share price volatility
Over the last 12 months, Aquestive Therapeutics's shares have ranged in value from as little as $2.595 up to $6.997. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aquestive Therapeutics's is 3.3349. This would suggest that Aquestive Therapeutics's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Aquestive Therapeutics overview
Aquestive Therapeutics, Inc. , a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; and Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery. The company's proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. Its proprietary pipeline of complex molecule products include AQST-108, a sublingual film formulation of epinephrine for the treatment of anaphylaxis; and AQST-305, a sublingual film formulation of octreotide for the treatment of acromegaly. Further, the company develops KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease. Aquestive Therapeutics, Inc.
Stocks similar to Aquestive Therapeutics
Aquestive Therapeutics in the news
Netflix shares fall near pre-pandemic level as investors fear slowing subscriber growth, competition
Stocks making the biggest moves midday: Netflix, Kohl's, Wynn Resorts, General Motors and more
RBC upgrades Comcast to outperform on subscriber growth
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Haemonetics Corporation stock in Canada
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.